Active Fatty Acid Binding Protein 1 (FABP1) Mus musculus (Mouse) Active protein

FABP-1; FABPL; L-FABP; LFABP; Liver-type fatty acid-binding protein; Fatty Acid Binding Protein 1, Liver

Add to Cart Distributors
Overview
Properties
  • Buffer Formulation20mM Tris, 150mM NaCl, pH8.0, containing 1mM EDTA, 1mM DTT, 0.01% SKL, 5% Trehalose and Proclin300.
  • Traits Freeze-dried powder, Purity > 90%
  • Isoelectric Pointn/a
Share your citation Upload your experimental result Review Leave a message
Loading...

Share a new citation as an author

Upload your experimental result

Review

Please attach serial No. on instruction manual

Contact us

Please fill in the blank.

Name*
Organization
Address
E-mail address*
Telephone
Inquiry*
Verification code* CheckCode
  • Active Fatty Acid Binding Protein 1 (FABP1) Packages (Simulation)
  • Active Fatty Acid Binding Protein 1 (FABP1) Packages (Simulation)
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered

Activity test

Usage

Reconstitute in 20mM Tris, 150mM NaCl (PH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex.

Storage

Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.

Stability

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

Citations

  • Acute Kidney Injury after Using Contrast during Cardiac Catheterization in Children with Heart DiseasePubmed:25120320
  • Ex vivo use of a Rho-kinase inhibitor during renal preservation improves graft function upon reperfusionPubmed:25555715
  • Controlled Rewarming after Hypothermia: Adding a New Principle to Renal PreservationPubMed: 26053383
  • The role of serum I-FABP concentration in assessment of small intestine mucosa among HIV-infected patientsContent: Early
  • Kidney transplantation after oxygenated machine perfusion preservation with Custodiol‐N solutionPubMed: 25882869
  • Prediction of renal function upon reperfusion by ex situ controlled oxygenated rewarmingpubmed:27718228
  • The Importance of Liver-Fatty Acid Binding Protein in Diagnosis of Liver Damage in Patients with Acute Hepatitispubmed:28571184
  • Plasma Free Fatty Acids and their Binding Proteins in Preterm InfantsPubmed:30045009
  • Isolated kidney perfusion: the influence of pulsatile flowPubmed:29301417
  • Circulating fatty acid-binding protein 1 (FABP1) and nonalcoholic fatty liver disease in patients with type 2 diabetes mellitusPubmed: 32038102
  • FABP1 and FABP2 as markers of diabetic nephropathyPubmed: 32922200
  • Profile of Intestinal Barrier Functional Markers in Italian Patients with Diarrhea-Predominant IBS: Preliminary Data from a Low-FODMAPs diet Trial
  • The Effects of Beverage Intake after Exhaustive Exercise on Organ Damage, Inflammation and Oxidative Stress in Healthy Males34071378
  • TCA Cycle and Fatty Acids Oxidation Reflect Early Cardiorenal Damage in Normoalbuminuric Subjects with Controlled Hypertension34356333
  • Association of plasma fatty acid-binding protein 3 with estimated glomerular filtration rate in patients with type 2 diabetes mellitus34975301

Recommend products